Citation: Mengxue He, Ling Yu, Yuanyuan Yang, Binhua Zou, Wen Ma, Meng Yu, Jiandong Lu, Guoliang Xiong, Zhiqiang Yu, Aimin Li. Delivery of triptolide with reduction-sensitive polymer nanoparticles for liver cancer therapy on patient-derived xenografts models[J]. Chinese Chemical Letters, ;2020, 31(12): 3178-3182. doi: 10.1016/j.cclet.2020.05.034 shu

Delivery of triptolide with reduction-sensitive polymer nanoparticles for liver cancer therapy on patient-derived xenografts models

Mengxue He ^{a, 1} ,
Ling Yu ^{b, 1} ,
Yuanyuan Yang ^d ,
Binhua Zou ^d ,
Wen Ma ^d ,
Meng Yu ^d ,
Jiandong Lu ^c ,
Guoliang Xiong ^{c, *,} ,
Zhiqiang Yu ^{d, *,} ,
Aimin Li ^{a, *,}

a.
Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510315, China
b.
Traditional Chinese Medicine Department, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China
c.
Department of Nephrology, Shenzhen Traditional Chinese Medicine Hospital, Guangzhou University of Chinese Medicine, Shenzhen 518033, China
d.
School of Pharmaceutical Sciences, Guangdong Provincial Key Laboratory of New Drug Screening, Southern Medical University, Guangzhou 510515, China

xiongguoliangzyy@outlook.com

yuzq@smu.edu.cn

liaimin2005@163.com

Received Date: 3 March 2020
Revised Date: 20 May 2020
Accepted Date: 22 May 2020
Available Online: 26 May 2020

Figures(6)

Hepatocellular carcinoma (HCC) has become the fourth predominant cause of cancer-related deaths worldwide, and HCC is still one of the worst prognoses for survival as it is poorly responsive to both chemotherapy and surgical treatment due to drug resistance and great toxic effects. Triptolide (TP), a key ingredient from the traditional Chinese medical herb, has been utilized to treat inflammation and antitumor for centuries. However, investigations of this potent agent have been met with only limited success due to the severe systemic toxicities in patients and low water solubility as well as its high toxicity over the past two decades. Herein, we reported the development of a reduction-responsive drug delivery system loaded with TP for glutathione (GSH)-triggered drug release for cancer therapy. With the GSH-sensitive TP loaded nanoparticles, the remarkable increases in tumor accumulation and amelioration of drug toxicity in animals are demonstrated, which is likely due to sustained stepwise release of active TP within cancer cells. Moreover, in a patient-derived tumor xenograft model of liver cancer, administration of tritolide nanoparticles enhances the antitumor efficacy relative to administration of free TP. These findings indicate that GSH-sensitive release of TP may be a promising strategy for cancer treatment.
- Triptolide,
- Hepatocellular carcinoma,
- Reduction-sensitive polymer,
- Patient-derived xenografts,
- Drug therapy
1. [1]
  D. Dimitroulis, C. Damaskos, S. Valsami, et al., World J. Gastroenterol. 23 (2017) 5282-5294. doi: 10.3748/wjg.v23.i29.5282
2. [2]
  M.A. Avila, C. Berasain, B. Sangro, et al., Oncogene 25 (2006) 3866-3884. doi: 10.1038/sj.onc.1209550
3. [3]
  Y. Sun, W. Ma, Y. Yang, et al., Asian J. Pharm. Sci. 14 (2019) 581-594. doi: 10.1016/j.ajps.2019.04.005
4. [4]
  Y. Cheng, P. Zhao, S. Wu, et al., Int. J. Pharm. 545 (2018) 261-273. doi: 10.1016/j.ijpharm.2018.05.007
5. [5]
  Y. Ding, S. Li, W. Ge, et al., Eur. J. Med. Chem. 183 (2019) 111706.
6. [6]
  T. Kawaoka, H. Aikata, T. Kobayashi, et al., Hepatol. Res. 48 (2018) 1118-1130. doi: 10.1111/hepr.13232
7. [7]
  J.M. Llovet, S. Ricci, V. Mazzaferro, et al., N. Engl. J. Med. 359 (2008) 378-390. doi: 10.1056/NEJMoa0708857
8. [8]
  P.A. Phillips, V. Dudeja, J.A. McCarroll, et al., Cancer Res. 67 (2007) 9407-9416. doi: 10.1158/0008-5472.CAN-07-1077
9. [9]
  D. Ling, H. Xia, W. Park, et al., ACS Nano 8 (2014) 8027-8039. doi: 10.1021/nn502074x
10. [10]
  T. Tengchaisri, R. Chawengkirttikul, N. Rachaphaew, et al., Cancer Lett. 133 (1998) 169-175. doi: 10.1016/S0304-3835(98)00222-5
11. [11]
  W. Ma, S.N. Sha, P.L. Chen, et al., Adv. Healthc. Mater. 9 (2019) e1901100.
12. [12]
  Y. Yu, Q. Xu, S. He, et al., Coord. Chem. Rev. 387 (2019) 154-179. doi: 10.1016/j.ccr.2019.01.020
13. [13]
  Y. Xiao, F. An, J. Chen, et al., Small 15 (2019) e1903121. doi: 10.1002/smll.201903121
14. [14]
  Y. Cao, Z. Wei, M. Li, et al., Curr. Cancer. Drug. Targets 19 (2019) 338-347. doi: 10.2174/1568009618666180629150927
15. [15]
  Q. Hu, L. Bai, Z. Zhu, et al., Chin. Chem. Lett. 31 (2020) 915-918. doi: 10.1016/j.cclet.2020.01.008
16. [16]
  Z. Chen, C. Wu, Z.F. Zhang, et al., Chin. Chem. Lett. 29 (2018) 1601-1608. doi: 10.1016/j.cclet.2018.08.007
17. [17]
  Y. Sun, A. Zhan, S. Zhou, et al., Chin. Chem. Lett. 30 (2019) 1435-1439. doi: 10.1016/j.cclet.2019.05.001
18. [18]
  X. Pu, L. Zhao, J. Li, et al., Acta Biomater. 88 (2019) 357-369. doi: 10.1016/j.actbio.2019.02.039
19. [19]
  Y. Yang, X. Wang, G. Liao, et al., J. Colloid Interf. Sci. 509 (2017) 515-521.
20. [20]
  L. Zong, X. Li, H. Wang, et al., Int. J. Pharm. 531 (2017) 108-117. doi: 10.1016/j.ijpharm.2017.08.082
21. [21]
  H. Jin, C. Wan, Z. Zou, et al., ACS Nano 12 (2018) 3295-3310. doi: 10.1021/acsnano.7b08148
22. [22]
  H. Wang, Z. Lu, L. Wang, et al., Cancer Res. 24 (2017) 6963-6974.
23. [23]
  W. Zhang, X. Hu, Q. Shen, et al., Nat. Commun. 10 (2019) 1704. doi: 10.1038/s41467-019-09566-3
24. [24]
  C. Yang, L. Xing, X. Chang, et al., Mol. Pharm. 17 (2020) 1300-1309. doi: 10.1021/acs.molpharmaceut.9b01318
25. [25]
  Y. Yang, Q. Chen, J. Lin, et al., Curr. Med. Chem. 26 (2019) 2285-2296. doi: 10.2174/0929867326666190409130207
26. [26]
  X. Pu, L. Zhao, J. Li, et al., Acta Biomater. 88 (2019) 357-369. doi: 10.1016/j.actbio.2019.02.039
27. [27]
  M. Yu, D. Su, Y. Yang, et al., ACS Appl. Mater. Inter. 11 (2019) 176-186. doi: 10.1021/acsami.8b16219
28. [28]
  Y. Liu, Y. Kim, N. Siriwon, et al., Biotechnol. Bioeng. 115 (2018) 1403-1415. doi: 10.1002/bit.26566
29. [29]
  Y. Yang, X. Wang, G. Liao, et al., J. Colloid Interf. Sci. 509 (2017) 515-521.
30. [30]
  Z. Soe, B. Poudel, T. Nguyen, et al., Asian J. Pharm. Sci. 14 (2019) 40-51. doi: 10.1016/j.ajps.2018.09.004
31. [31]
  Y. Li, W. Hong, H. Zhang, et al., J. Control. Release 317 (2020) 232-245. doi: 10.1016/j.jconrel.2019.11.031
32. [32]
  Q. Chen, Y. Yang, X. Lin, et al., Chem. Commun. (Camb.) 54 (2018) 5369-5372. doi: 10.1039/C8CC02791A
33. [33]
  W. Tao, Z. He, Asian J. Pharm. Sci. 13 (2018) 101-112. doi: 10.1016/j.ajps.2017.11.002
34. [34]
  X. Xu, P. Saw, W. Tao, et al., Adv. Mater. 29 (2017) 1700141. doi: 10.1002/adma.201700141
1. [1]
  Zhiyu Yu , Xiang Luo , Cheng Zhang , Xin Lu , Xiaohui Li , Pan Liao , Zhongqiu Liu , Rong Zhang , Shengtao Wang , Zhiqiang Yu , Guochao Liao . Mitochondria-targeted carrier-free nanoparticles based on dihydroartemisinin against hepatocellular carcinoma. Chinese Chemical Letters, 2024, 35(10): 109519-. doi: 10.1016/j.cclet.2024.109519
2. [2]
  Qiuye Wang , Yabing Sun , Liangxue Lai , Haijing Cui , Yonglong Ye , Ming Yang , Weihao Zhu , Bo Yuan , Quanliang Mao , Wenzhi Ren , Aiguo Wu . MMP-9-responsive probe for fluorescence-magnetic resonance dual-mode imaging of hepatocellular carcinoma models with different metastatic capacities. Chinese Chemical Letters, 2025, 36(4): 110212-. doi: 10.1016/j.cclet.2024.110212
3. [3]
  Jun Xiong , Ke-Ke Chen , Neng-Bin Xie , Wei Chen , Wen-Xuan Shao , Tong-Tong Ji , Si-Yu Yu , Yu-Qi Feng , Bi-Feng Yuan . Demethylase-assisted site-specific detection of N¹-methyladenosine in RNA. Chinese Chemical Letters, 2024, 35(5): 108953-. doi: 10.1016/j.cclet.2023.108953
4. [4]
  Jinyu Guo , Yandai Lin , Shaohua He , Yueqing Chen , Fenglu Li , Renjie Ruan , Gaoxing Pan , Hexin Nan , Jibin Song , Jin Zhang . Utilizing dual-responsive iridium(Ⅲ) complex for hepatocellular carcinoma: Integrating photoacoustic imaging with chemotherapy and photodynamic therapy. Chinese Chemical Letters, 2024, 35(9): 109537-. doi: 10.1016/j.cclet.2024.109537
5. [5]
  Jiechen Liu , Xiaoguang Li , Ruiyang Xia , Yuqi Wang , Fenghe Zhang , Yongzhi Pang , Qing Li . Efficient suppression of oral squamous cell carcinoma through spatial dimension conversion drug delivery systems-enabled immunomodulatory-photodynamic therapy. Chinese Chemical Letters, 2024, 35(12): 109619-. doi: 10.1016/j.cclet.2024.109619
6. [6]
  Chunlei Dai , Liying Wang , Xinru You , Yi Zhao , Zhong Cao , Jun Wu . Coffee-derived self-anti-inflammatory polymer as drug nanocarrier for enhanced rheumatoid arthritis treatment. Chinese Chemical Letters, 2025, 36(3): 109869-. doi: 10.1016/j.cclet.2024.109869
7. [7]
  Ningyue Xu , Jun Wang , Lei Liu , Changyang Gong . Injectable hydrogel-based drug delivery systems for enhancing the efficacy of radiation therapy: A review of recent advances. Chinese Chemical Letters, 2024, 35(8): 109225-. doi: 10.1016/j.cclet.2023.109225
8. [8]
  Yihan Zhou , Duo Gao , Yaying Wang , Li Liang , Qingyu Zhang , Wenwen Han , Jie Wang , Chunliu Zhu , Xinxin Zhang , Yong Gan . Worm-like micelles facilitate the intestinal mucus diffusion and drug accumulation for enhancing colorectal cancer therapy. Chinese Chemical Letters, 2024, 35(6): 108967-. doi: 10.1016/j.cclet.2023.108967
9. [9]
  Tingting Hu , Chao Shen , Xueyan Wang , Fengbo Wu , Zhiyao He . Tumor microenvironment-sensitive polymeric nanoparticles for synergetic chemo-photo therapy. Chinese Chemical Letters, 2024, 35(11): 109562-. doi: 10.1016/j.cclet.2024.109562
10. [10]
  Haijun Shen , Yi Qiao , Chun Zhang , Yane Ma , Jialing Chen , Yingying Cao , Wenna Zheng . A matrix metalloproteinase-sensitive hydrogel combined with photothermal therapy for transdermal delivery of deferoxamine to accelerate diabetic pressure ulcer healing. Chinese Chemical Letters, 2024, 35(12): 110283-. doi: 10.1016/j.cclet.2024.110283
11. [11]
  Yunyan Li , Zimin Cai , Zhicheng Wang , Sifeng Zhu , Wendian Liu , Cheng Wang . Construction of biomimetic hybrid nanovesicles based on M1 macrophage-derived exosomes for therapy of cancer. Chinese Chemical Letters, 2025, 36(4): 109942-. doi: 10.1016/j.cclet.2024.109942
12. [12]
  Mengyuan Li , Xitong Ren , Yanmei Gao , Mengyao Mu , Shiping Zhu , Shufang Tian , Minghua Lu . Constructing bifunctional magnetic porous poly(divinylbenzene) polymer for high-efficient removal and sensitive detection of bisphenols. Chinese Chemical Letters, 2024, 35(12): 109699-. doi: 10.1016/j.cclet.2024.109699
13. [13]
  Jing REN , Ruikui YAN , Xiaoli CHEN , Huali CUI , Hua YANG , Jijiang WANG . Synthesis and fluorescence sensing of a highly sensitive and multi-response cadmium coordination polymer. Chinese Journal of Inorganic Chemistry, 2025, 41(3): 574-586. doi: 10.11862/CJIC.20240287
14. [14]
  Linghui Zou , Meng Cheng , Kaili Hu , Jianfang Feng , Liangxing Tu . Vesicular drug delivery systems for oral absorption enhancement. Chinese Chemical Letters, 2024, 35(7): 109129-. doi: 10.1016/j.cclet.2023.109129
15. [15]
  Fengjie Liu , Fansu Meng , Zhenjiang Yang , Huan Wang , Yuehong Ren , Yu Cai , Xingwang Zhang . Exosome-biomimetic nanocarriers for oral drug delivery. Chinese Chemical Letters, 2024, 35(9): 109335-. doi: 10.1016/j.cclet.2023.109335
16. [16]
  Jiayu Huang , Kuan Chang , Qi Liu , Yameng Xie , Zhijia Song , Zhiping Zheng , Qin Kuang . Fe-N-C nanostick derived from 1D Fe-ZIFs for Electrocatalytic oxygen reduction. Chinese Journal of Structural Chemistry, 2023, 42(10): 100097-100097. doi: 10.1016/j.cjsc.2023.100097
17. [17]
  Ke Gong , Jinghan Liao , Jiangtao Lin , Quan Wang , Zhihua Wu , Liting Wang , Jiali Zhang , Yi Dong , Yourong Duan , Jianhua Chen . Mitochondria-targeted nanoparticles overcome chemoresistance via downregulating BACH1/CD47 axis in ovarian carcinoma. Chinese Chemical Letters, 2024, 35(5): 108888-. doi: 10.1016/j.cclet.2023.108888
18. [18]
  Yujie Li , Ya-Nan Wang , Yin-Gen Luo , Hongcai Yang , Jinrui Ren , Xiao Li . Advances in synthetic biology-based drug delivery systems for disease treatment. Chinese Chemical Letters, 2024, 35(11): 109576-. doi: 10.1016/j.cclet.2024.109576
19. [19]
  Shaoqing Du , Xinyong Liu , Xueping Hu , Peng Zhan . Targeting novel sites represents an effective strategy for combating drug resistance. Chinese Chemical Letters, 2025, 36(1): 110378-. doi: 10.1016/j.cclet.2024.110378
20. [20]
  Qijie Gong , Jian Song , Yihui Song , Kai Tang , Panpan Yang , Xiao Wang , Min Zhao , Liang Ouyang , Li Rao , Bin Yu , Peng Zhan , Saiyang Zhang , Xiaojin Zhang . New techniques and strategies in drug discovery (2020–2024 update). Chinese Chemical Letters, 2025, 36(3): 110456-. doi: 10.1016/j.cclet.2024.110456

Get Citation

PDF

XML

Metrics

PDF Downloads(18)
Abstract views(1379)
HTML views(138)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142